Loading organizations...
Emerald Mutual Funds delivers equity portfolio management services, primarily through its Emerald Growth Fund and Emerald Finance and Banking Innovation Fund. The firm employs a proprietary 10-Step research process that underscores hands-on, fundamental analysis. This methodical approach is specifically designed to identify unrecognized and under-researched companies, forming the cornerstone of their investment strategies.
The firm commenced managing capital in 1992, subsequently developing into a comprehensive family of financial advisory entities. This evolution was spurred by a core insight: a commitment to intensive, proprietary research could consistently unearth undervalued equities overlooked by general market analysis. This belief has since guided their differentiated approach to asset management.
Emerald’s offerings cater to a diverse client base, encompassing both institutional and individual investors through mutual funds and separate account management. The company’s overarching vision is to provide sustained equity investment performance by rigorously applying its distinctive research framework. They continuously strive to identify promising enterprises and generate value for their clients.
Emerald Investment Managers has 1 tracked investment across 1 company. The latest tracked deal is $40.0M Series A in Transcend Therapeutics in February 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 23, 2023 | Transcend Therapeutics | $40.0M Series A | Falcon Edge Capital, Integrated | Kevin Ryan, Global Founders Capital |